Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-18-015118)

Filing Details

Accession Number:: 0000899243-18-015118
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-06-05 16:48:21
Reporting Period:: 2018-06-01

Accepted Time:: 2018-06-05 16:48:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492674	T2 Biosystems Inc.	TTOO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1292650	B David Elsbree	101 Hartwell Ave Lexington MA 02421		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-06-02	18,000	$0.00	68,000	No	4	M	Direct
Common Stock	Acquisiton	2018-06-01	4,225	$7.65	10,000	No	4	P	Indirect	By spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	P	Indirect	By spouse

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Acquisiton	2017-06-02	18,000	$0.00	18,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
18,000			No	4	M	Direct

Footnotes

The restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
On June 2, 2017 the reporting person was granted 18,000 RSUs that vested on June 2, 2018.